Daniel B. Ravicher
Contributor since: 2010
Company: Daniel B. Ravicher, Esq.
Latest Articles
Celgene Asserts More Revlimid Patents, Seeks New Ones To 2031
Thoughts On The Celgene Revlimid Markman Hearing
Analysis Of Oral Argument In Vringo Vs. Google Patent Infringement Appeal
Addressing Revlimid Patents Questions From Celgene's Q1 2014 Call
Day 5 Of The Juniper Vs. Palo Alto Patent Trial
Day 4 Of The Juniper Vs. Palo Alto Patent Trial
Day 3 Of The Juniper Vs. Palo Alto Patent Trial
Day 2 Of The Juniper Vs. Palo Alto Patent Trial
Day 1 Of The Juniper Vs. Palo Alto Patent Trial
Did Palo Alto Really 'Win' Juniper Patent Decision?
New Patents Could Sustain Allergan Restasis Franchise Until 2024
Expected Decision In Avanir Nuedexta Patent Litigation
Are Facebook, Twitter And Google Infringing Vringo's Quantumstream Patents?
Vringo Vs. Google: Ongoing Royalty Prediction
Might Other Companies Be Liable If Herbalife Is A Pyramid?
VirnetX Highly Likely To Get Apple Injunction
Google Request To Postpone Vringo Ongoing Royalty Motion Ignored
Did Vringo Traders Overreact To Google's Flip Flop?
Google Flip Flops, Concedes Vringo Entitled To Ongoing Royalties
ParkerVision Unlikely To Be Bought
Will Patent Office Eliminate Vringo's Right To Future Royalties From Google?
Vringo Verdict And Future Royalties Against Google On Shaky Ground
Vringo Vs. Google: Outcome Probabilities
Will ParkerVision Be Bought By A Tech Giant?
Is VirnetX Really A 'Fairytale'?
Report Raising Vivus Qsymia Patent Infringement Concerns Was Not Competent
Will American Express, Visa And Mastercard Get Swiped By SmartMetric?
Appeals Court Affirms Hospira Cancer Drug Win Over Sanofi-Aventis
Rambus, Micron and Hynix Patent Suits: It Ain't Over Yet
Rambus Likely to Jump Upon Pending Appeals Court Decisions
MoneyGram Up on Patent Appeal Victory
Appeals Court Backs Merck Against Teva in Temodar Fight